Alberta Investment Management Corp Reduces Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Alberta Investment Management Corp lowered its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 41.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,346 shares of the company’s stock after selling 8,842 shares during the quarter. Alberta Investment Management Corp’s holdings in HealthEquity were worth $1,185,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of HQY. Wasatch Advisors LP grew its position in HealthEquity by 6.6% during the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after purchasing an additional 483,269 shares during the last quarter. Vaughan Nelson Investment Management L.P. grew its holdings in shares of HealthEquity by 36.7% during the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock valued at $69,034,000 after buying an additional 226,563 shares during the last quarter. Barclays PLC increased its position in shares of HealthEquity by 209.3% in the 3rd quarter. Barclays PLC now owns 166,492 shares of the company’s stock valued at $13,628,000 after acquiring an additional 112,667 shares during the period. Thrivent Financial for Lutherans raised its stake in HealthEquity by 33.3% in the 3rd quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company’s stock worth $24,033,000 after acquiring an additional 73,404 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new position in HealthEquity in the 3rd quarter worth $5,675,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Stock Down 2.8 %

HQY opened at $108.60 on Friday. The company has a fifty day moving average of $103.66 and a two-hundred day moving average of $92.05. The stock has a market capitalization of $9.41 billion, a price-to-earnings ratio of 99.63, a PEG ratio of 1.63 and a beta of 0.55. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the previous year, the business posted $0.40 earnings per share. On average, research analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Mizuho assumed coverage on HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective on the stock. Barrington Research upped their target price on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Monday, December 2nd. BTIG Research raised their price target on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. JMP Securities lifted their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. Finally, Bank of America increased their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $110.71.

Insider Transactions at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the sale, the director now owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 39,000 shares of company stock valued at $3,895,788 in the last three months. 2.20% of the stock is currently owned by company insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.